Perfromance Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-327
Closed -$202K 205
2024
Q3
$202K Buy
+327
New +$194K 0.01% 185
2023
Q2
Sell
-348
Closed -$201K 192
2023
Q1
$201K Sell
348
-20
-5% -$11.3K 0.01% 174
2022
Q4
$203K Sell
368
-26
-7% -$13.8K 0.01% 161
2022
Q3
$200K Hold
394
0.01% 158
2022
Q2
$214K Buy
394
+26
+7% +$14.3K 0.01% 157
2022
Q1
$217K Buy
368
+14
+4% +$8.04K 0.01% 162
2021
Q4
$236K Buy
+354
New +$221K 0.01% 160

Other funds holding TMO

Perfromance Wealth Partners's TMO Position: Q4 2024 in Review

Perfromance Wealth Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 327 shares — an estimated $202K sold.

Perfromance Wealth Partners first reported a position in TMO in Q4 2021 and held it in 7 quarters. The position peaked at $236K in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Perfromance Wealth Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Perfromance Wealth Partners sold 327 Thermo Fisher Scientific shares in Q4 2024, an estimated $202K.
  • Perfromance Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 7 quarters.
  • Perfromance Wealth Partners's Thermo Fisher Scientific position peaked at $236K in Q4 2021.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Perfromance Wealth Partners's 13F filing for Q4 2024, filed 17 Jan 2025.